Application of Random Effects Models and Other Methods to the Analysis of Multidimensional Quality of Life Data in an Aids Clinical Trial
Datos Bibliográficos
| ID | 9104970 |
|---|---|
| Autores | Albert W Wu (0000-0001-6189-7120, Johns Hopkins University, autor de correspondencia), Sarah M Gray (0000-0002-4025-6487, Johns Hopkins University), Ronald Brookmeyer (Johns Hopkins University) |
| Año | 1999 |
| Volumen | 37 |
| Número | 3 |
| Páginas | 249-258 |
| Fecha de publicación | 1999-03-01 |
| Peer Reviewed | Sí |
| Open Access | No |
| Tipo | ARTICLE |
| Revista | Medical Care (JOURNAL) |
| Identificadores de la revista | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editorial | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/00005650-199903000-00005 |
| PMID | 10098569 |
| OpenAlex | W2072215970 |
| Idioma | EN |
| Citas recibidas | 3 |
| Referencias citadas | 22 |
BACKGROUND: Current analytic methods applied to multidimensional health-related quality of life (HRQOL) data do not borrow strength across analyses and do not produce summary estimates of effect. OBJECTIVES: To compare a random effects modelling approach for the analysis of multidimensional HRQOL data to the following: (1) separate analyses for each dimension; (2) O'Brien's global test procedure; and (3) multivariate analysis of variance (MANOVA). RESEARCH DESIGN: Randomized clinical trial comparing 3 treatments (Trimethoprim-Sulfamethoxazole [TS], Dapsone-Trimethoprim [DT], and Clindamycin-Primaquine [CP] for Pneumocystis carinii pneumonia [PCP]). SUBJECTS: Patients with PCP enrolled in AIDS Clinical Trials Group Protocol 108. MEASURES: A 33-item battery assessing 7 dimensions of HRQOL: physical functioning, pain, energy, general health perceptions, disability, pulmonary symptoms, and constitutional symptoms. RESULTS: Analyses focused on changes in score from baseline to Day 7 (n = 145). Separate analyses for each dimension suggested a trend favoring CP versus TS, but using a Bonferroni correction no differences were statistically significant. O'Brien's global procedure for a test of no-treatment effect versus superiority of one treatment yielded P = 0.07. MANOVA did not reveal significant differences among treatment groups. A random effects model using fixed treatment and dimension effects and separate random effects for each person showed a significant overall treatment effect (P = 0.02); changes in scores for CP averaged 10 points greater than for TS. CONCLUSIONS: Random-effects models provide a flexible class of models for analyzing multidimensional quality of life data and estimating treatment effects because they borrow strength across dimensions
Analysis of variance · Bonferroni correction · Clinical trial · Meta-analysis · Multivariate analysis of variance · Quality of life (healthcare) · Random effects model · Randomized controlled trial · Repeated measures design · Statistics · HIV/AIDS Research and Interventions · Internal Medicine · Mathematics · Medicine · Pneumocystis jirovecii pneumonia detection and treatment · Spondyloarthritis Studies and Treatments
Random-Effects Models for Longitudinal Data
No Adjustments Are Needed for Multiple Comparisons
Simultaneous Factor Analysis in Several Populations
The Effects of Antihypertensive Therapy on the Quality of Life
Statistical analysis of longitudinal quality of life data with missing measurements
The Sickness Impact Profile
A Perceived Health Index for Use in Persons With Advanced HIV Disease
A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study
Quality of Life, Health Status, and Clinical Research
How the power of Manova can both increase and decrease as a function of the intercorrelations among the dependent variables
| Obras citantes distintas | 3 |
|---|---|
| Citas por año | 0,12 |
| Intervalo de citas | 2001 - 2003 (3) |
| Velocidad de citación | historical |
| Altamente citado | No |
| Tipos de cita | Neutras: 3 |